0001104659-24-088377.txt : 20240812 0001104659-24-088377.hdr.sgml : 20240812 20240812163052 ACCESSION NUMBER: 0001104659-24-088377 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 17 FILED AS OF DATE: 20240812 DATE AS OF CHANGE: 20240812 EFFECTIVENESS DATE: 20240812 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Global Medical REIT Inc. CENTRAL INDEX KEY: 0001533615 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction IRS NUMBER: 464757266 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-281484 FILM NUMBER: 241197220 BUSINESS ADDRESS: STREET 1: 7373 WISCONSIN AVENUE STREET 2: SUITE 800 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 202-524-6851 MAIL ADDRESS: STREET 1: 7373 WISCONSIN AVENUE STREET 2: SUITE 800 CITY: BETHESDA STATE: MD ZIP: 20814 FORMER COMPANY: FORMER CONFORMED NAME: SCOOP MEDIA, INC. DATE OF NAME CHANGE: 20111027 S-8 1 tm2421279d1_s8.htm FORM S-8

 

As filed with the Securities and Exchange Commission on August 12, 2024

 

Registration No. 333-

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

 

 

FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933

 

 

 

GLOBAL MEDICAL REIT INC.
(Exact name of registrant as specified in its charter)
 
Maryland   46-4757266
(State or Other Jurisdiction
of Incorporation or Organization)		   (I.R.S. Employer
Identification No.)
     
7373 Wisconsin Avenue, Suite 800
Bethesda, Maryland		   20814
(Address of Principal Executive Offices)   (Zip Code)

   
Global Medical REIT Inc. 2016 Equity Incentive Plan
(Full title of the plan)

   

Jeffrey M. Busch
7373 Wisconsin Avenue, Suite 800
Bethesda, Maryland 20814

(Name and address of agent for service)

   
(202) 524-6851
(Telephone number, including area code, of agent for service)

 

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

 

Large accelerated filer x   Accelerated filer ¨
Non-accelerated filer ¨   Smaller reporting company ¨
      Emerging growth company ¨ 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act of 1933, as amended (the “Securities Act”). ¨

 

 

 

 

 

INTRODUCTORY STATEMENT

 

Global Medical REIT Inc., a Maryland corporation (the “Registrant”), is filing this Registration Statement on Form S-8 (the “Registration Statement”) for the purpose of registering the offer and sale of an additional 1,650,000 shares of its common stock, par value $0.001 per share (“Stock”), issuable pursuant to the terms of the Global Medical REIT Inc. 2016 Equity Incentive Plan, as amended from time to time (the “Plan”).

 

Pursuant to General Instruction E to Form S-8, the Registrant hereby incorporates by reference into this Registration Statement the contents of the prior registration statements on Form S-8 filed by the Registrant with the Securities and Exchange Commission (the “Commission”) on (i) June 30, 2016 (File No. 333-212343) relating to the Plan, (ii) June 21, 2019 (File No. 333-232279) relating to an amendment to the Plan, and (iii) March 2, 2022 (File No. 333-263219) relating to an amendment to the Plan (collectively, the “Prior Registration Statements”), including periodic reports that the Registrant filed after the Prior Registration Statements to maintain current information about the Registrant except to the extent otherwise updated or modified by this Registration Statement. The additional shares of Stock that are the subject of this Registration Statement were authorized pursuant to an amendment to the Plan that was approved by the Registrant’s stockholders on May 15, 2024, which Stock consists of shares reserved and available for delivery with respect to awards under the Plan and additional shares that may again become available for delivery with respect to awards under the Plan pursuant to the share counting, share recycling and other terms and conditions of the Plan.

 

PART I
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

 

In accordance with the instructional note to Part I of Form S-8, as promulgated by the SEC, the information specified by Part I of Form S-8 has been omitted from this Registration Statement. The documents containing the information specified in Part I will be delivered to the participants in the Plan covered by this Registration Statement as required by Rule 428(b)(1) under the Securities Act.

 

PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

 

Item 8.Exhibits.

 

Exhibit
Number		  Description
4.1  Articles of Restatement of Global Medical REIT Inc. (incorporated herein by reference to Exhibit 3.1 to the Company’s Report on Form 10-Q as filed with the SEC on August 8, 2018).
    
4.2  Fourth Amended and Restated Bylaws of Global Medical REIT Inc., adopted as of December 7, 2022 (incorporated herein by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K as filed with the SEC on December 7, 2022).
    
4.3  Global Medical REIT Inc. 2016 Equity Incentive Plan (as amended through May 15, 2024) (incorporated  herein by reference to Appendix A of the Company's Definitive Proxy Statement on Schedule 14A as filed with the SEC on April 1, 2024).
    
5.1*  Opinion of Venable LLP as to the legality of the securities being registered.
    
23.1*  Consent of Deloitte & Touche, LLP.
    
23.2*  Consent of Venable LLP (contained in Exhibit 5.1 hereto).
    
24.1*  Power of Attorney (included as part of the signature pages to this Registration Statement).
    
107.1*  Calculation of Filing Fee Tables

 

 

* Filed herewith.

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Bethesda, State of Maryland, on August 12, 2024.

 

  GLOBAL MEDICAL REIT INC.
   
  By: /s/ Jeffrey M. Busch
    Name: Jeffrey M. Busch
    Title: Chief Executive Officer (Principal Executive Officer)

 

POWER OF ATTORNEY

 

KNOWN ALL PERSONS BY THESE PRESENTS, pursuant to the requirements of the Securities Act, that each person whose signature appears below authorizes and appoints Jeffrey M. Busch as such person’s true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for such person and in such person’s name, place and stead in any and all capacities to sign any and all amendments (including post-effective amendments) to this Registration Statement and any additional registration statement pursuant to Rule 462(b) under the Securities Act, and to file the same with all exhibits thereto, and other documents in connection therewith, with the Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully and to all intents and purposes as such person might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or such person’s or their substitute or substitutes may lawfully do or cause to be done by virtue hereof.

 

Signature   Title
     
/s/ Jeffrey M. Busch   Chief Executive Officer and Director
Jeffrey M. Busch   (Principal Executive Officer)
     
/s/ Robert J. Kiernan   Chief Financial Officer
Robert J. Kiernan   (Principal Financial and Accounting Officer)
     
/s/ Henry Cole   Director
Henry Cole    
     
/s/ Paula Crowley   Director
Paula Crowley    
     
/s/ Matthew Cypher   Director
Matthew Cypher    
     
/s/ Zhang Huiqi   Director
Zhang Huiqi    
     
/s/ Ronald Marston   Director
Ronald Marston    
     
/s/ Lori Wittman   Director
Lori Wittman    
     

 

3

 

 EX-5.1 2 tm2421279d1_ex5-1.htm EXHIBIT 5.1

Exhibit 5.1 

 

 

 

 

August 12, 2024

 

 

Global Medical REIT Inc.

7373 Wisconsin Avenue

Suite 800

Bethesda, MD 20814

 

Re:Global Medical REIT Inc.

Registration Statement on Form S-8

 

Ladies and Gentlemen:

 

We have served as Maryland counsel to Global Medical REIT Inc., a Maryland corporation (the “Company”), in connection with certain matters of Maryland law arising out of the registration by the Company of 1,650,000 shares (the “Shares”) of common stock, par value $0.001 per share (the “Common Stock”), of the Company, covered by the above-referenced Registration Statement, and all amendments and supplements thereto (the “Registration Statement”), filed by the Company with the United States Securities and Exchange Commission (the “Commission”) pursuant to the Securities Act of 1933, as amended (the “1933 Act”). The Shares will be issued pursuant to the Company’s 2016 Equity Incentive Plan, as amended from time to time (the “Plan”).

 

In connection with our representation of the Company, and as a basis for the opinion hereinafter set forth, we have examined originals, or copies certified or otherwise identified to our satisfaction, of the following documents (hereinafter collectively referred to as the “Documents”):

 

1.       The Registration Statement in the form in which it was transmitted to the Commission under the 1933 Act;

 

2.       The charter of the Company (the “Charter”), certified by the State Department of Assessments and Taxation of Maryland (the “SDAT”);

 

3.       The Fourth Amended and Restated Bylaws of the Company, certified as of the date hereof by an officer of the Company;

 

4.       A certificate of the SDAT as to the good standing of the Company, dated as of a recent date;

 

5.       Resolutions (the “Resolutions”) adopted by the Board of Directors of the Company (the “Board”) relating to, among other matters, the Plan and the issuance of the Shares, certified as of the date hereof by an officer of the Company;

 

6.       The Plan, certified as of the date hereof by an officer of the Company;

 

 

 

 

Global Medical REIT Inc.

August 12, 2024

Page 2

 

 

7.       A certificate executed by an officer of the Company, dated as of the date hereof; and

 

8.       Such other documents and matters as we have deemed necessary or appropriate to express the opinion set forth in this letter, subject to the assumptions, limitations and qualifications stated herein.

 

In expressing the opinion set forth below, we have assumed the following:

 

1.       Each individual executing any of the Documents, whether on behalf of such individual or another person, is legally competent to do so.

 

2.       Each individual executing any of the Documents on behalf of a party (other than the Company) is duly authorized to do so.

 

3.       Each of the parties (other than the Company) executing any of the Documents has duly and validly executed and delivered each of the Documents to which such party is a signatory, and such party’s obligations set forth therein are legal, valid and binding and are enforceable in accordance with all stated terms.

 

4.       All Documents submitted to us as originals are authentic. The form and content of all Documents submitted to us as unexecuted drafts do not differ in any respect relevant to this opinion from the form and content of such Documents as executed and delivered. All Documents submitted to us as certified or photostatic copies conform to the original documents. All signatures on all Documents are genuine. All public records reviewed or relied upon by us or on our behalf are true and complete. All representations, warranties, statements and information contained in the Documents are true and complete. There has been no oral or written modification of or amendment to any of the Documents, and there has been no waiver of any provision of any of the Documents, by action or omission of the parties or otherwise.

 

5.       The Shares will not be issued in violation of the restrictions on transfer and ownership contained in Article VII of the Charter.

 

6.       Upon issuance of any of the Shares, the total number of shares of Common Stock issued and outstanding will not exceed the total number of shares of Common Stock that the Company is then authorized to issue under the Charter or the Plan.

 

7.       Each option, award, right or other security exercisable or exchangeable for a Share pursuant to the Plan (each, an “Award”) will be duly authorized and validly granted in accordance with the Plan, and each Award will be exercised or exchanged in accordance with the terms of the Plan and such Award, including any option or award agreement entered into in connection therewith.

 

 

 

 

Global Medical REIT Inc.

August 12, 2024

Page 3

 

 

8.       Upon the granting of any Award, the total number of Shares issuable under all then-outstanding Awards will not exceed the total number of shares of Common Stock that the Company is then authorized to issue under the Plan (including, without limitation, if any previously issued Award has expired, was forfeited or was terminated without having been exercised or was paid in cash without a requirement for the delivery of Shares, the “Reallocation of Shares” provisions of the Plan).

 

Based upon the foregoing, and subject to the assumptions, limitations and qualifications stated herein, it is our opinion that:

 

1.       The Company is a corporation duly incorporated and existing under and by virtue of the laws of the State of Maryland and is in good standing with the SDAT.

 

2.       The Shares have been duly authorized and, when issued and delivered by the Company pursuant to the Registration Statement, the Plan, any applicable Award and the Resolutions, will be validly issued, fully paid and nonassessable.

 

The foregoing opinion is limited to the laws of the State of Maryland and we do not express any opinion herein concerning United States federal law or the laws of any other jurisdiction. We express no opinion as to the applicability or effect of federal or state securities laws, including the securities laws of the State of Maryland, or as to federal or state laws regarding fraudulent transfers. To the extent that any matter as to which our opinion is expressed herein would be governed by any jurisdiction other than the State of Maryland, we do not express any opinion on such matter.

 

The opinion expressed herein is limited to the matters specifically set forth herein and no other opinion shall be inferred beyond the matters expressly stated. We assume no obligation to supplement this opinion if any applicable law changes after the date hereof or if we become aware of any fact that might change the opinion expressed herein after the date hereof.

 

This opinion is being furnished to you for submission to the Commission as an exhibit to the Registration Statement. We hereby consent to the filing of this opinion as an exhibit to the Registration Statement and to the use of the name of our firm therein. In giving this consent, we do not admit that we are within the category of persons whose consent is required by Section 7 of the 1933 Act.

 

  Very truly yours,
   
  /s/ Venable LLP

 

 

 

 

 EX-23.1 3 tm2421279d1_ex23-1.htm EXHIBIT 23.1

 

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in this Registration Statement on Form S-8 of our reports dated February 28, 2024 relating to the financial statements of Global Medical REIT Inc. and the effectiveness of Global Medical REIT Inc.'s internal control over financial reporting, appearing in the Annual Report on Form 10-K of Global Medical REIT Inc. for the year ended December 31, 2023.

 

/s/ Deloitte & Touche LLP

 

McLean, Virginia

 

August 12, 2024

 

 

 

 EX-FILING FEES 4 tm2421279d1_ex-filingfees.htm EX-FILING FEES EX-FILING FEES
S-8 S-8 EX-FILING FEES 0001533615 Global Medical REIT Inc. Fees to be Paid 0001533615 2024-08-08 2024-08-08 0001533615 1 2024-08-08 2024-08-08 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

S-8

Global Medical REIT Inc.

Table 1: Newly Registered Securities

Security Type

Security Class Title

Fee Calculation Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price

Fee Rate

Amount of Registration Fee

1 Equity Common Stock, par value $0.001 per share Other 1,650,000 $ 9.15 $ 15,097,500.00 0.0001476 $ 2,228.39

Total Offering Amounts:

$ 15,097,500.00

$ 2,228.39

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 2,228.39

Offering Note

1

(1) The Form S-8 registration statement to which this Exhibit 107.1 is attached (the "Registration Statement") registers 1,650,000 shares of common stock of Global Medical REIT Inc., $0.001 par value per share (the "Common Stock"), of Global Medical REIT Inc., a Maryland corporation, that may be delivered with respect to awards under the Global Medical REIT Inc. 2016 Equity Incentive Plan (as amended from time to time, the "Plan"), which shares consist of shares of Common Stock reserved and available for delivery with respect to awards under the Plan and additional shares of Common Stock that may again become available for delivery with respect to awards under the Plan pursuant to the reallocation provisions of the Plan. (2) Pursuant to Rule 416(a) under the Securities Act, the Registration Statement shall be deemed to cover an indeterminate number of additional shares of Common Stock that may become issuable as a result of stock splits, stock dividends, or similar transactions pursuant to the adjustment or anti-dilution provisions of the Plan. (3) The proposed maximum offering price per share and proposed maximum aggregate offering price for the shares of Stock covered by this Registration Statement have been estimated solely for purposes of calculating the registration fee pursuant to Rules 457(c) and 457(h) under the Securities Act based upon the average of the high and low prices of a share of Common Stock as reported on the New York Stock Exchange on August 7, 2024, which was equal to $9.15.
GRAPHIC 5 image_001.jpg GRAPHIC begin 644 image_001.jpg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image_002.jpg GRAPHIC begin 644 image_002.jpg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end XML 8 R1.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Submission
Aug. 08, 2024
Submission [Line Items]  
Central Index Key 0001533615
Registrant Name Global Medical REIT Inc.
Form Type S-8
Submission Type S-8
Fee Exhibit Type EX-FILING FEES
XML 9 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Offerings - Offering: 1
Aug. 08, 2024
USD ($)
shares
Offering:  
Fee Previously Paid false
Other Rule true
Security Type Equity
Security Class Title Common Stock, par value $0.001 per share
Amount Registered | shares 1,650,000
Proposed Maximum Offering Price per Unit 9.15
Maximum Aggregate Offering Price $ 15,097,500.00
Fee Rate 0.01476%
Amount of Registration Fee $ 2,228.39
Offering Note (1) The Form S-8 registration statement to which this Exhibit 107.1 is attached (the "Registration Statement") registers 1,650,000 shares of common stock of Global Medical REIT Inc., $0.001 par value per share (the "Common Stock"), of Global Medical REIT Inc., a Maryland corporation, that may be delivered with respect to awards under the Global Medical REIT Inc. 2016 Equity Incentive Plan (as amended from time to time, the "Plan"), which shares consist of shares of Common Stock reserved and available for delivery with respect to awards under the Plan and additional shares of Common Stock that may again become available for delivery with respect to awards under the Plan pursuant to the reallocation provisions of the Plan. (2) Pursuant to Rule 416(a) under the Securities Act, the Registration Statement shall be deemed to cover an indeterminate number of additional shares of Common Stock that may become issuable as a result of stock splits, stock dividends, or similar transactions pursuant to the adjustment or anti-dilution provisions of the Plan. (3) The proposed maximum offering price per share and proposed maximum aggregate offering price for the shares of Stock covered by this Registration Statement have been estimated solely for purposes of calculating the registration fee pursuant to Rules 457(c) and 457(h) under the Securities Act based upon the average of the high and low prices of a share of Common Stock as reported on the New York Stock Exchange on August 7, 2024, which was equal to $9.15.
XML 10 R3.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Fees Summary
Aug. 08, 2024
USD ($)
Fees Summary [Line Items]  
Total Offering $ 15,097,500.00
Total Fee Amount 2,228.39
Total Offset Amount 0.00
Net Fee $ 2,228.39
EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.2.u1 html 2 19 1 false 1 0 false 3 false false R1.htm 995210 - Document - Submission Sheet http://xbrl.sec.gov/ffd/role/document/submissionTable Submission Cover 1 false false R2.htm 995211 - Document - Offerings Sheet http://xbrl.sec.gov/ffd/role/document/feesOfferingTable Offerings Cover 2 false false R3.htm 995215 - Document - Fees Summary Sheet http://xbrl.sec.gov/ffd/role/document/feesSummaryTable Fees Summary Cover 3 false false All Reports Book All Reports tm2421279d1_ex-filingfees.htm http://xbrl.sec.gov/dei/2024 http://xbrl.sec.gov/ffd/2024q2 false false JSON 17 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tm2421279d1_ex-filingfees.htm": { "dts": { "inline": { "local": [ "tm2421279d1_ex-filingfees.htm" ] }, "schema": { "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd" ] } }, "keyStandard": 19, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 1, "memberCustom": 0, "hidden": { "total": 6, "http://xbrl.sec.gov/dei/2024": 2, "http://xbrl.sec.gov/ffd/2024q2": 4 }, "contextCount": 2, "entityCount": 1, "segmentCount": 1, "elementCount": 107, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/ffd/2024q2": 18, "http://xbrl.sec.gov/dei/2024": 3 }, "report": { "R1": { "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable", "longName": "995210 - Document - Submission", "shortName": "Submission", "isDefault": "true", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": null, "uniqueAnchor": null }, "R2": { "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable", "longName": "995211 - Document - Offerings", "shortName": "Offerings", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Cover", "order": "2", "firstAnchor": { "contextRef": "offrl_1", "name": "ffd:FeesOthrRuleFlg", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "tm2421279d1_ex-filingfees.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "offrl_1", "name": "ffd:FeesOthrRuleFlg", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "tm2421279d1_ex-filingfees.htm", "first": true, "unique": true } }, "R3": { "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable", "longName": "995215 - Document - Fees Summary", "shortName": "Fees Summary", "isDefault": "false", "groupType": "Fee_Exhibit", "subGroupType": "", "menuCat": "Cover", "order": "3", "firstAnchor": { "contextRef": "rc", "name": "ffd:TtlOfferingAmt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "tm2421279d1_ex-filingfees.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "rc", "name": "ffd:TtlOfferingAmt", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "tm2421279d1_ex-filingfees.htm", "first": true, "unique": true } } }, "tag": { "ffd_AggtRedRpPricFsclYr": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "AggtRedRpPricFsclYr", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year", "terseLabel": "Aggregate Redeemed or Repurchased, FY" } } }, "auth_ref": [ "r1" ] }, "ffd_AggtRedRpPricPrrFsclYr": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "AggtRedRpPricPrrFsclYr", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year", "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY" } } }, "auth_ref": [ "r1" ] }, "ffd_AggtSalesPricFsclYr": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "AggtSalesPricFsclYr", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Aggregate Sales Price, Fiscal Year", "terseLabel": "Aggregate Sales Price" } } }, "auth_ref": [ "r1" ] }, "ffd_AmtRedCdts": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "AmtRedCdts", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Amount of Redemption Credits", "terseLabel": "Redemption Credits" } } }, "auth_ref": [ "r1" ] }, "ffd_AmtSctiesRcvd": { "xbrltype": "nonNegativeDecimal2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "AmtSctiesRcvd", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Amount of Securities Received", "terseLabel": "Amount of Securities Received", "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)" } } }, "auth_ref": [ "r6" ] }, "ffd_AmtSctiesRegd": { "xbrltype": "nonNegativeDecimal2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "AmtSctiesRegd", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Amount of Securities Registered", "terseLabel": "Amount Registered", "documentation": "The amount of securities being registered." } } }, "auth_ref": [ "r1" ] }, "ffd_CeasedOprsDt": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "CeasedOprsDt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Ceased Operations Date", "terseLabel": "Ceased Operations Date" } } }, "auth_ref": [] }, "ffd_CfwdFormTp": { "xbrltype": "formTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "CfwdFormTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Carry Forward Form Type", "terseLabel": "Carry Forward Form Type", "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)." } } }, "auth_ref": [ "r2" ] }, "ffd_CfwdPrevslyPdFee": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "CfwdPrevslyPdFee", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Carry Forward Previously Paid Fee", "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward", "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)." } } }, "auth_ref": [ "r2" ] }, "ffd_CfwdPrrFctvDt": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "CfwdPrrFctvDt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Carry Forward Prior Effective Date", "terseLabel": "Carry Forward Initial Effective Date", "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)." } } }, "auth_ref": [ "r2" ] }, "ffd_CfwdPrrFileNb": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "CfwdPrrFileNb", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Carry Forward File Number", "terseLabel": "Carry Forward File Number", "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used." } } }, "auth_ref": [ "r2" ] }, "ffd_CmbndPrspctsItemAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "CmbndPrspctsItemAxis", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Combined Prospectus Item [Axis]", "terseLabel": "Combined Prospectus", "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission." } } }, "auth_ref": [ "r1" ] }, "ffd_CmbndPrspctsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "CmbndPrspctsLineItems", "lang": { "en-us": { "role": { "label": "Combined Prospectus [Line Items]", "terseLabel": "Combined Prospectus:" } } }, "auth_ref": [ "r1" ] }, "ffd_CmbndPrspctsTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "CmbndPrspctsTable", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Combined Prospectus [Table]", "terseLabel": "Combined Prospectus Table" } } }, "auth_ref": [ "r1" ] }, "ffd_CombinedProspectusTableNa": { "xbrltype": "naItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "CombinedProspectusTableNa", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Combined Prospectus Table [N/A]", "terseLabel": "Combined Prospectus Table N/A" } } }, "auth_ref": [] }, "ffd_CshPdByRegistrantInTx": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "CshPdByRegistrantInTx", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Cash Paid by Registrant in Transaction", "terseLabel": "Cash Consideration Paid", "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)." } } }, "auth_ref": [ "r12" ] }, "ffd_CshRcvdByRegistrantInTx": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "CshRcvdByRegistrantInTx", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Cash Received by Registrant in Transaction", "terseLabel": "Cash Consideration Received", "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)." } } }, "auth_ref": [ "r12" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r0" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r0" ] }, "ffd_FeeAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "FeeAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable", "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Fee Amount", "terseLabel": "Amount of Registration Fee", "documentation": "Total amount of registration fee (amount due after offsets)." } } }, "auth_ref": [ "r1" ] }, "ffd_FeeExhibitTp": { "xbrltype": "feeExhibitTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "FeeExhibitTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Fee Exhibit Type", "terseLabel": "Fee Exhibit Type" } } }, "auth_ref": [] }, "ffd_FeeIntrstAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "FeeIntrstAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Fee Interest Amount", "terseLabel": "Interest Amount" } } }, "auth_ref": [ "r1" ] }, "ffd_FeeNote": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "FeeNote", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Fee Note", "terseLabel": "Fee Note" } } }, "auth_ref": [ "r1" ] }, "ffd_FeeNoteMaxAggtOfferingPric": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "FeeNoteMaxAggtOfferingPric", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Fee Note Maximum Aggregate Offering Price", "terseLabel": "Fee Note MAOP" } } }, "auth_ref": [ "r1" ] }, "ffd_FeeRate": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "FeeRate", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable", "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Fee Rate", "terseLabel": "Fee Rate", "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission." } } }, "auth_ref": [ "r1" ] }, "ffd_FeesOthrRuleFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "FeesOthrRuleFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Fees, Other Rule [Flag]", "terseLabel": "Other Rule", "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due." } } }, "auth_ref": [ "r1" ] }, "ffd_FeesSummaryLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "FeesSummaryLineItems", "lang": { "en-us": { "role": { "label": "Fees Summary [Line Items]", "terseLabel": "Fees Summary:" } } }, "auth_ref": [ "r1" ] }, "ffd_FnlPrspctsFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "FnlPrspctsFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Final Prospectus [Flag]", "terseLabel": "Final Prospectus" } } }, "auth_ref": [ "r1" ] }, "ffd_FormTp": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "FormTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Form Type", "terseLabel": "Form Type" } } }, "auth_ref": [] }, "ffd_GnlInstrIIhiFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "GnlInstrIIhiFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "General Instruction II.H,I [Flag]", "terseLabel": "General Instruction II.H,I" } } }, "auth_ref": [] }, "ffd_IssrBizAdrCity": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "IssrBizAdrCity", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Issuer Business Address, City", "terseLabel": "City" } } }, "auth_ref": [] }, "ffd_IssrBizAdrStatOrCtryCd": { "xbrltype": "stateOrCountryCodeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "IssrBizAdrStatOrCtryCd", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Issuer Business Address, State or Country Code", "terseLabel": "State or Country Code" } } }, "auth_ref": [] }, "ffd_IssrBizAdrStrt1": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "IssrBizAdrStrt1", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Issuer Business Address, Street 1", "terseLabel": "Street 1" } } }, "auth_ref": [] }, "ffd_IssrBizAdrStrt2": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "IssrBizAdrStrt2", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Issuer Business Address, Street 2", "terseLabel": "Street 2" } } }, "auth_ref": [] }, "ffd_IssrBizAdrZipCd": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "IssrBizAdrZipCd", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Issuer Business Address, Zip Code", "terseLabel": "Zip Code" } } }, "auth_ref": [] }, "ffd_IssrNm": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "IssrNm", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Issuer Name", "terseLabel": "Issuer Name" } } }, "auth_ref": [] }, "ffd_MaxAggtOfferingPric": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "MaxAggtOfferingPric", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Maximum Aggregate Offering Price", "terseLabel": "Maximum Aggregate Offering Price", "documentation": "The maximum aggregate offering price for the offering that is being registered." } } }, "auth_ref": [ "r1" ] }, "ffd_MaxOfferingPricPerScty": { "xbrltype": "nonNegativeDecimal4lItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "MaxOfferingPricPerScty", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Maximum Offering Price per Security", "terseLabel": "Proposed Maximum Offering Price per Unit", "documentation": "The maximum offering price per share/unit being registered." } } }, "auth_ref": [ "r1" ] }, "ffd_NetFeeAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "NetFeeAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Net Fee Amount", "terseLabel": "Net Fee" } } }, "auth_ref": [ "r1" ] }, "ffd_NetSalesAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "NetSalesAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Net Sales Amount", "terseLabel": "Net Sales" } } }, "auth_ref": [ "r1" ] }, "ffd_NrrtvDsclsr": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "NrrtvDsclsr", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Narrative Disclosure", "terseLabel": "Narrative Disclosure" } } }, "auth_ref": [ "r1" ] }, "ffd_NrrtvMaxAggtAmt": { "xbrltype": "nonNegativeDecimal2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "NrrtvMaxAggtAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Narrative Disclosure, Maximum Aggregate Offering Amount", "terseLabel": "Narrative - Max Aggregate Offering Amount" } } }, "auth_ref": [ "r1" ] }, "ffd_NrrtvMaxAggtOfferingPric": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "NrrtvMaxAggtOfferingPric", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Narrative Disclosure, Maximum Aggregate Offering Price", "terseLabel": "Narrative - Max Aggregate Offering Price" } } }, "auth_ref": [ "r1" ] }, "ffd_OfferingAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OfferingAxis", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Offering [Axis]", "terseLabel": "Offering", "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission." } } }, "auth_ref": [] }, "ffd_OfferingLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OfferingLineItems", "lang": { "en-us": { "role": { "label": "Offering [Line Items]", "terseLabel": "Offering:" } } }, "auth_ref": [] }, "ffd_OfferingNote": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OfferingNote", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Offering Note", "terseLabel": "Offering Note" } } }, "auth_ref": [ "r1" ] }, "ffd_OfferingSctyTitl": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OfferingSctyTitl", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable", "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Offering Security Title", "terseLabel": "Security Class Title", "documentation": "The title of the class of securities being registered (for each class being registered)." } } }, "auth_ref": [ "r1" ] }, "ffd_OfferingSctyTp": { "xbrltype": "securityTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OfferingSctyTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Offering Security Type", "terseLabel": "Security Type", "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\"" } } }, "auth_ref": [ "r1" ] }, "ffd_OfferingTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OfferingTable", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Offering [Table]", "terseLabel": "Offering:" } } }, "auth_ref": [] }, "ffd_OfferingTableNa": { "xbrltype": "naItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OfferingTableNa", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Offering Table [N/A]", "terseLabel": "Offering Table N/A" } } }, "auth_ref": [] }, "ffd_OffsetAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetAxis", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset [Axis]", "terseLabel": "Offset", "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission." } } }, "auth_ref": [ "r1" ] }, "ffd_OffsetClmInitlFilgDt": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetClmInitlFilgDt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Claim Initial Filing Date", "terseLabel": "Initial Filing Date", "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ." } } }, "auth_ref": [ "r5", "r8" ] }, "ffd_OffsetClmdAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetClmdAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Claimed Amount", "terseLabel": "Fee Offset Claimed", "documentation": "The amount of offsetting fees being claimed." } } }, "auth_ref": [ "r5", "r8" ] }, "ffd_OffsetClmdInd": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetClmdInd", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Claimed Indicator", "terseLabel": "Offset Claimed" } } }, "auth_ref": [ "r1" ] }, "ffd_OffsetExpltnForClmdAmt": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetExpltnForClmdAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Explanation for Claimed Amount", "terseLabel": "Explanation for Claimed Amount" } } }, "auth_ref": [ "r1" ] }, "ffd_OffsetLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetLineItems", "lang": { "en-us": { "role": { "terseLabel": "Offset:", "label": "Offset [Line Items]" } } }, "auth_ref": [ "r1" ] }, "ffd_OffsetNote": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetNote", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Note", "terseLabel": "Offset Note" } } }, "auth_ref": [ "r1" ] }, "ffd_OffsetPrrFeeAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetPrrFeeAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior Fee Amount", "terseLabel": "Fee Paid with Fee Offset Source", "documentation": "The fee prevoiusly paid from which an offset is being derived." } } }, "auth_ref": [ "r5", "r8" ] }, "ffd_OffsetPrrFileNb": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetPrrFileNb", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior File Number", "terseLabel": "File Number", "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used." } } }, "auth_ref": [ "r5", "r8" ] }, "ffd_OffsetPrrFilerNm": { "xbrltype": "filerNameItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetPrrFilerNm", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior Filer Name", "terseLabel": "Registrant or Filer Name", "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid." } } }, "auth_ref": [ "r5", "r8" ] }, "ffd_OffsetPrrFormTp": { "xbrltype": "formTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetPrrFormTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior Form Type", "terseLabel": "Form or Filing Type", "documentation": "The Form Type of the offset filing." } } }, "auth_ref": [ "r5", "r8" ] }, "ffd_OffsetPrrNbOfUnsoldScties": { "xbrltype": "nonNegativeIntegerItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetPrrNbOfUnsoldScties", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior Unsold Number of Securities", "terseLabel": "Unsold Securities Associated with Fee Offset Claimed", "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset." } } }, "auth_ref": [ "r5", "r8" ] }, "ffd_OffsetPrrSctyTitl": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetPrrSctyTitl", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior Security Title", "terseLabel": "Security Title Associated with Fee Offset Claimed", "documentation": "The title of the class of securities from which offset fees were derived." } } }, "auth_ref": [ "r5", "r8" ] }, "ffd_OffsetPrrSctyTp": { "xbrltype": "securityTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetPrrSctyTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior Security Type", "terseLabel": "Security Type Associated with Fee Offset Claimed", "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\"" } } }, "auth_ref": [ "r5", "r8" ] }, "ffd_OffsetPrrUnsoldOfferingAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetPrrUnsoldOfferingAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Prior Unsold Offering Amount", "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed", "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset." } } }, "auth_ref": [ "r5", "r8" ] }, "ffd_OffsetSrcFilgDt": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetSrcFilgDt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Offset Source Filing Date", "terseLabel": "Filing Date", "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset." } } }, "auth_ref": [ "r5", "r8" ] }, "ffd_OffsetTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetTable", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "terseLabel": "Offset Payment:", "label": "Offset [Table]" } } }, "auth_ref": [ "r1" ] }, "ffd_OffsetTableNa": { "xbrltype": "naItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "OffsetTableNa", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Offset Table [N/A]", "terseLabel": "Offset Table N/A" } } }, "auth_ref": [] }, "ffd_PrevslyPdFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "PrevslyPdFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable", "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Fee Previously Paid [Flag]", "terseLabel": "Fee Previously Paid" } } }, "auth_ref": [] }, "ffd_RegnFileNb": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "RegnFileNb", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Registration File Number", "terseLabel": "Registration File Number" } } }, "auth_ref": [] }, "ffd_RptgFsclYrEndDt": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "RptgFsclYrEndDt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Reporting Fiscal Year End Date", "terseLabel": "Reporting FY End Date" } } }, "auth_ref": [] }, "ffd_Rule011Flg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule011Flg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 0-11 [Flag]", "terseLabel": "Rule 0-11" } } }, "auth_ref": [] }, "ffd_Rule011a2OffsetFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule011a2OffsetFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 0-11(a)(2) Offset", "label": "Rule 0-11(a)(2) Offset [Flag]" } } }, "auth_ref": [] }, "ffd_Rule415a6Flg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule415a6Flg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 415(a)(6) [Flag]", "terseLabel": "Rule 415(a)(6)", "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward." } } }, "auth_ref": [ "r2" ] }, "ffd_Rule429AggtOfferingAmt": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule429AggtOfferingAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Aggregate Offering Amount", "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered", "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement." } } }, "auth_ref": [ "r3" ] }, "ffd_Rule429CmbndPrspctsFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule429CmbndPrspctsFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Combined Prospectus [Flag]", "terseLabel": "Rule 429", "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429." } } }, "auth_ref": [ "r3" ] }, "ffd_Rule429EarlierFileNb": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule429EarlierFileNb", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Earlier File Number", "terseLabel": "File Number", "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429." } } }, "auth_ref": [ "r3" ] }, "ffd_Rule429EarlierFormTp": { "xbrltype": "formTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule429EarlierFormTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Earlier Form Type", "terseLabel": "Form Type", "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)." } } }, "auth_ref": [ "r3" ] }, "ffd_Rule429InitlFctvDt": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule429InitlFctvDt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Initial Effective Date", "terseLabel": "Initial Effective Date", "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429." } } }, "auth_ref": [ "r3" ] }, "ffd_Rule429NbOfUnsoldScties": { "xbrltype": "nonNegativeDecimal2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule429NbOfUnsoldScties", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Number Of Unsold Securities", "terseLabel": "Amount of Securities Previously Registered", "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429." } } }, "auth_ref": [ "r3" ] }, "ffd_Rule429PrspctsNote": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule429PrspctsNote", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Prospectus Note", "terseLabel": "Combined Prospectus Note" } } }, "auth_ref": [ "r1" ] }, "ffd_Rule429SctyTitl": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule429SctyTitl", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Security Title", "terseLabel": "Security Class Title" } } }, "auth_ref": [ "r1" ] }, "ffd_Rule429SctyTp": { "xbrltype": "securityTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule429SctyTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable" ], "lang": { "en-us": { "role": { "label": "Rule 429 Security Type", "terseLabel": "Security Type" } } }, "auth_ref": [ "r1" ] }, "ffd_Rule457aFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule457aFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(a) [Flag]", "terseLabel": "Rule 457(a)", "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due." } } }, "auth_ref": [ "r4" ] }, "ffd_Rule457bOffsetFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule457bOffsetFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(b) Offset [Flag]", "terseLabel": "Rule 457(b) Offset", "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)." } } }, "auth_ref": [ "r5" ] }, "ffd_Rule457fFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule457fFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(f) [Flag]", "terseLabel": "Rule 457(f)", "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due." } } }, "auth_ref": [ "r6" ] }, "ffd_Rule457oFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule457oFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(o) [Flag]", "terseLabel": "Rule 457(o)", "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due." } } }, "auth_ref": [ "r7" ] }, "ffd_Rule457pOffsetFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule457pOffsetFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(p) Offset [Flag]", "terseLabel": "Rule 457(p) Offset", "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)." } } }, "auth_ref": [ "r8" ] }, "ffd_Rule457rFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule457rFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(r) [Flag]", "terseLabel": "Rule 457(r)" } } }, "auth_ref": [ "r9" ] }, "ffd_Rule457sFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule457sFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(s) Flag", "terseLabel": "Rule 457(s)" } } }, "auth_ref": [ "r10" ] }, "ffd_Rule457uFlg": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Rule457uFlg", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Rule 457(u) [Flag]", "terseLabel": "Rule 457(u)", "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due." } } }, "auth_ref": [ "r11" ] }, "ffd_Scties424iAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Scties424iAxis", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Securities, 424I [Axis]", "terseLabel": "Securities, 424I" } } }, "auth_ref": [ "r1" ] }, "ffd_Scties424iLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Scties424iLineItems", "lang": { "en-us": { "role": { "label": "Securities, 424I [Line Items]", "terseLabel": "Securities, 424I:" } } }, "auth_ref": [ "r1" ] }, "ffd_Scties424iTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Scties424iTable", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/securities424iTable" ], "lang": { "en-us": { "role": { "label": "Securities, 424I [Table]", "terseLabel": "Securities, 424I Table" } } }, "auth_ref": [ "r1" ] }, "ffd_Securities424iTableNa": { "xbrltype": "naItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "Securities424iNa", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Securities 424I [N/A]", "terseLabel": "Securities 424I N/A" } } }, "auth_ref": [] }, "ffd_SubmissionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "SubmissionLineItems", "lang": { "en-us": { "role": { "label": "Submission [Line Items]", "terseLabel": "Items" } } }, "auth_ref": [] }, "ffd_SubmissnTp": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "SubmissnTp", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/submissionTable" ], "lang": { "en-us": { "role": { "label": "Submission Type", "terseLabel": "Submission Type" } } }, "auth_ref": [] }, "ffd_TermntnCmpltnWdrwl": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "TermntnCmpltnWdrwl", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable" ], "lang": { "en-us": { "role": { "label": "Termination / Completion / Withdrawal Statement", "terseLabel": "Termination / Withdrawal Statement" } } }, "auth_ref": [] }, "ffd_TtlFeeAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "TtlFeeAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Total Fee Amount", "terseLabel": "Total Fee Amount" } } }, "auth_ref": [ "r1" ] }, "ffd_TtlFeeAndIntrstAmt": { "xbrltype": "nonNegativeDecimal2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "TtlFeeAndIntrstAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Total Fee and Interest Amount", "terseLabel": "Total Fee and Interest Amount" } } }, "auth_ref": [ "r1" ] }, "ffd_TtlOfferingAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "TtlOfferingAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Total Offering Amount", "terseLabel": "Total Offering" } } }, "auth_ref": [ "r1" ] }, "ffd_TtlOffsetAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "TtlOffsetAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Total Offset Amount", "terseLabel": "Total Offset Amount" } } }, "auth_ref": [ "r1" ] }, "ffd_TtlPrevslyPdAmt": { "xbrltype": "nonNegative1TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "TtlPrevslyPdAmt", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Total Previously Paid Amount", "terseLabel": "Previously Paid Amount" } } }, "auth_ref": [ "r1" ] }, "ffd_TtlTxValtn": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "TtlTxValtn", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable" ], "lang": { "en-us": { "role": { "label": "Total Transaction Valuation", "terseLabel": "Total Transaction Valuation" } } }, "auth_ref": [ "r1" ] }, "ffd_TxValtn": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "TxValtn", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Transaction Valuation", "terseLabel": "Transaction Valuation" } } }, "auth_ref": [] }, "ffd_ValSctiesRcvd": { "xbrltype": "nonNegative100TMonetary2ItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "ValSctiesRcvd", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Value of Securities Received", "terseLabel": "Value of Securities Received", "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)" } } }, "auth_ref": [ "r6" ] }, "ffd_ValSctiesRcvdPerShr": { "xbrltype": "nonNegativeDecimal4lItemType", "nsuri": "http://xbrl.sec.gov/ffd/2024q2", "localname": "ValSctiesRcvdPerShr", "presentation": [ "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable" ], "lang": { "en-us": { "role": { "label": "Value of Securities Received, Per Share", "terseLabel": "Value of Securities Received, Per Share", "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "415", "Subsection": "a" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "429" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457", "Subsection": "b" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457", "Subsection": "f" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457", "Subsection": "o" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457", "Subsection": "p" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457", "Subsection": "r" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457", "Subsection": "s" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "457", "Subsection": "u" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Subsection": "f", "Section": "457" } } } ZIP 18 0001104659-24-088377-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-24-088377-xbrl.zip M4$L#!!0 ( ,>##%GZ!>M6<0H $IV%6B1,J6;"FRICR./>M*XG'9 MGJK9IRV(A$1L> 4 =>S7;SYYY(I$Y(' M_MD'LVE\(,RW IO[D[,/Y_<7U]:HU38;[5FLUES=M0, MQ*1E]GJ]UAQAM 2H/W>Y_ZT>%&=ST)%P^0HHCL3 ;<,X:G%?*NI;K AO+Q<4 M@;NM9#(#Y3(X;ILGFY G$/F">1VLB8P V^S/7^^^+,%5-?P2M*4$]>4X$!Y5 MH&+$U-&-MM[N%I#HDEDKB.!WD1E;D:;5;28483 M)F!%^S@#'(_M:D"8B &_M[7A6T(&#J,V?L"GXLIEP\L_]:OK+]8R=.FB3_S 9UHR#Q!\WL>%3&0CZ1BW M;>8OQY)16'H3>4QPB_C4 Z3 ;_\*%/@0:L0*?,7FZHZ-SS1A:82#C'P^U4VS MJPWO]=-!:P7#3KCOHY''I?0WXS]Y-/XKQB[G#A]QM9G"J;:F^?V(@0?T+WVP MUN*"^>!W[K5OL_EGMMA$M:<-#0.<\NBH:W8>3_&.3;A$7UO+9G$M;2]>J10C"2^Z%+M-:)<:JF$B8DT$D MRKS%2;R?:BU6!QBK")'#L-C,JU/Y)+=Q>LR9(+&@K#(K7EQ_7G6V\N(2X58] MY91N")8)[!JF8/L1ZA-5;(@JQ*1KG&8XEW/5:YEOUZS,9BI97>#Y?\2G(I\G#O7'_:=J9_(8E9%@P[20 MZ@-@AC:;JJ"(>#>1"V'=9GJI3/#Y#.3N'0II;1>",H;7T2:_W_B/L2+[2Q]3C+M1*YX)3MT'^P=PI4[ A M-HB$DA%J2\''*:CD_V%]TC9"]9&@R77J\HG?)Q;X,1,?"QH8J)6 &"@;]D17 MAA2B$4K#E)>0VGA2T$>!4H'7)\T.\\IJ#-?<>#2\H*X5N7$E2X(QN>(0J!," M&R=Y0%%!P:.R$X>K6E9V4;M%9BLXK^.VO2.[Z_GCT?7E\=;Z,I'H+RC_(XJX MXY-'%7%/4Q%\HY-5AER=JB!DYLOP6 W(L1M0E<<02>/3-(SWJT'FLC&$'5D- MLAS)HR+9[(9S;=7:3H81#O6XULW()Z)4QGW&"AK!$,/I-QX$U M+\FH>%1,.&#:(:7D[A3'.#'[Y(;-W 5)O 6*39O<,RL27/&=,H"S@WG7;/5H M-<- I9U[93-G\Z!P 9D=5H=S(@.7VV3D4NO;1Y+H3$=_Z!,:J2 ?$GSB9&/5 M?C("#!,11+ZM0SX.1/_OO?-/YU?=.B](N6R_+UMB\#==)[]^.;_Y3'2]7K-5 MR$QC'=N3'"(U^X(\0#FVG^5_+'\7+I62/& ?8Y<$]*/YQ VTN+7>1>YK5.>Y M!_ZK"G'_##QVGIG'6Q&$@824])7.N1=Y)#M^D%O8C.!D#P>4/Z#&>X6L9QR? M3R:"3> \4.+]Z2P?O8#?W@&CKU"9J:]"D9H5-7%D <>/WZ&V)/3+$_C7+B7T MO(BKYOO-&_/MF]62IW957(>4E517T&:NX_?(TB5FUIP M+\TFI.>MC/:TX47@>6#*>Q58WQHDI(),J1LQ\LYH&H9)0FR!X''OZ:)4^]>F M1J_\73D"T_=>W4@EHF(SLF-H0\##Q-,EB N3&@&N!+7BH%A*<.XIL 24<1 T MMD;P,!PSGQZTBW&;%C:D.ST>T8#<,P,ADS;IY- M2#SS#M\-6O'?'>6'%)QY)*9%],$;720LCB!E:0,&YA/9^(Q]H0)3/@R-Q] M578&R2':7\RT'6W8;K3;I\VCWNYB;VV(Y*VLCE9W7%9!N'\A$:M5&SX$BKK+ MJBNI(61_8XJZ(EB9MJNTY:*IWHLV^=&#TNT>M>N+2E;I[9(DM[:27-%;2-L@[3]@]2/L&6\T8^UT6D#_:>AG= MYS?:NFZCDIWAO M@?3S._!ILGG_Y9WWAJG8=3]%[/]N&]L7-/)3\FV![O.[:^_9\^VF*Y<R$Y1]K2*DT \*;I!< J7M_FR/ M[ZR*E.,:#?,:\B:H:(^M66#=J6,F6R4KB14K%?7WW'=C>YCQQQBM$.0);R8: M:%M>K#)B12A'84T"03;P+8KNL/B&QVR#/I;, P]S#=^L (9]J]!EYC_)<]#, MX8KI,&J!8D+!=*2]=R\-74XC3%H4GXF9VXYJ74,;'IB'Y,%A!*_!R;U^2D2Q M:2H5')'Q+0V^C@,>+8W\I!\56H7;8V(R-DJ]4 M+%SJHVU$&"2,-T!6JB#R%_@PT&8NG\97GC.N'!!$ALR*]4)G5-@2D*/0-5$;F+=&%J&+E>RD?Z"'(\O^&P8 *5*#AD8 M(B)^>)[L_G)-==3^=R15+$^ G"NNV]R--FOR*$D287;%YJ475D&VV87Q%=LR M"-%3UJ!I?KU56H<>@=26&DI4$VL7$(P62=JIL8M#(8I&C/F0^B!<8-C&ZWOF M+F+,H 'D(\DPV5TKT$X_8Q7<7AE8NBO8J7:$4BZNF00O_KY?A?P%02P$"% ,4 " #' M@PQ9^@7K5G$* !',P '0 @ $ =&TR-#(Q,C XML 19 tm2421279d1_ex-filingfees_htm.xml IDEA: XBRL DOCUMENT 0001533615 2024-08-08 2024-08-08 0001533615 1 2024-08-08 2024-08-08 iso4217:USD pure shares S-8 S-8 EX-FILING FEES 0001533615 Global Medical REIT Inc. false S-8 Global Medical REIT Inc. Equity Common Stock, par value $0.001 per share true 1650000 9.15 15097500.00 0.0001476 2228.39 15097500.00 2228.39 0.00 2228.39 (1) The Form S-8 registration statement to which this Exhibit 107.1 is attached (the "Registration Statement") registers 1,650,000 shares of common stock of Global Medical REIT Inc., $0.001 par value per share (the "Common Stock"), of Global Medical REIT Inc., a Maryland corporation, that may be delivered with respect to awards under the Global Medical REIT Inc. 2016 Equity Incentive Plan (as amended from time to time, the "Plan"), which shares consist of shares of Common Stock reserved and available for delivery with respect to awards under the Plan and additional shares of Common Stock that may again become available for delivery with respect to awards under the Plan pursuant to the reallocation provisions of the Plan. (2) Pursuant to Rule 416(a) under the Securities Act, the Registration Statement shall be deemed to cover an indeterminate number of additional shares of Common Stock that may become issuable as a result of stock splits, stock dividends, or similar transactions pursuant to the adjustment or anti-dilution provisions of the Plan. (3) The proposed maximum offering price per share and proposed maximum aggregate offering price for the shares of Stock covered by this Registration Statement have been estimated solely for purposes of calculating the registration fee pursuant to Rules 457(c) and 457(h) under the Securities Act based upon the average of the high and low prices of a share of Common Stock as reported on the New York Stock Exchange on August 7, 2024, which was equal to $9.15.